A Carrato

Author PubWeight™ 43.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. J Epidemiol Community Health 1999 4.43
2 Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health 2002 2.13
3 Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 1999 1.74
4 Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group. Ann Oncol 2003 1.37
5 Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med 2007 1.32
6 Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial. Ann Oncol 2005 1.21
7 Assessment of lifetime exposure to trihalomethanes through different routes. Occup Environ Med 2006 1.15
8 Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial. J Clin Oncol 2003 1.11
9 Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. Lancet 2000 1.11
10 UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. Br J Cancer 2010 1.10
11 Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study. Eur J Cancer 2013 1.03
12 Primary vulvar lymphoma presenting as a clitoral tumor. Acta Obstet Gynecol Scand 1992 1.02
13 Hodgkin's disease after treatment of non-Hodgkin's lymphoma. Cancer 1987 0.98
14 First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD). Crit Rev Oncol Hematol 2009 0.97
15 Coffee, pancreatic cancer, and K-ras mutations: updating the research agenda. J Epidemiol Community Health 2000 0.96
16 Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 2003 0.93
17 The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression. Biochim Biophys Acta 2000 0.93
18 Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg 2000 0.87
19 Mild pancreatic damage in acute viral hepatitis. Digestion 1989 0.85
20 Guidelines for the detection and treatment of liver metastases of colorectal cancer. Clin Transl Oncol 2007 0.84
21 Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours. Eur J Cancer Care (Engl) 2010 0.84
22 A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer. Ann Oncol 2011 0.84
23 Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study Group. Eur J Epidemiol 2000 0.83
24 Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR. Histopathology 2005 0.82
25 Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study. Ann Oncol 1998 0.82
26 Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group. Dig Dis Sci 1999 0.82
27 Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer. Lung Cancer 2000 0.81
28 A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). Cancer 1995 0.80
29 Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer. Ann Oncol 2005 0.80
30 Work in the textile industry in Spain and bladder cancer. Occup Environ Med 2007 0.79
31 Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II study. Ann Oncol 2003 0.79
32 Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study. Ann Oncol 2008 0.79
33 Detection of terminal deoxynucleotidyl transferase (TdT) by flow cytometry in leukemic disorders. J Histochem Cytochem 1989 0.78
34 IFN-gamma-regulated expression of a differentiation antigen of human cells. J Immunol 1988 0.78
35 Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study. Lung Cancer 2003 0.78
36 Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2001 0.78
37 Occupation and pancreatic cancer in Spain: a case-control study based on job titles. PANKRAS II Study Group. Int J Epidemiol 2000 0.78
38 Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists. Clin Transl Oncol 2014 0.77
39 Deposition-associated diseases related with a monoclonal compound. Clin Transl Oncol 2007 0.77
40 Detection of intracytoplasmic immunoglobulin by flow cytometry in B-cell malignancies. J Histochem Cytochem 1989 0.77
41 UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients. Oncology (Williston Park) 1999 0.76
42 TTD consensus document on the diagnosis and management of exocrine pancreatic cancer. Clin Transl Oncol 2014 0.76
43 A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.). Am J Clin Oncol 1992 0.75
44 Molecular biology of exocrine pancreatic cancer. Clin Transl Oncol 2006 0.75
45 [Fever of unknown origin as first manifestation of two cases of cervix carcinoma]. An Med Interna 2006 0.75
46 [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients]. Rev Clin Esp 1994 0.75
47 [Cytology and topography of the mesencephalic periaqueductal nuclei of Clemmys caspica leprosa]. Trab Inst Cajal Invest Biol 1978 0.75
48 Postnatal development of astrocytic glia in the cerebellum of Cyprinus carpio. Prog Clin Biol Res 1981 0.75
49 Morphometric changes between one-day-old and adult chicken neurons of the nucleus isthmi. Z Mikrosk Anat Forsch 1989 0.75
50 [Pituicytes and their relation to the nerve fibers of the neurohypophysis]. Trab Inst Cajal Invest Biol 1979 0.75
51 The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD). J Infus Chemother 1996 0.75
52 Blood vessel's wall and neurosecretion at the neurohypophysis. Trab Inst Cajal Invest Biol 1973 0.75
53 [Multiple hepatic lesions suggestive of metastases in a patient with colorectal cancer]. Rev Clin Esp 2009 0.75
54 [Systemic mastocytosis: systematic review]. An Med Interna 2008 0.75
55 [Castleman's disease: myth or reality? Comments with presentation of a case]. Rev Clin Esp 1980 0.75
56 Tegafur and uracil plus leucovorin in advanced colorectal cancer: a phase II trial. Clin Colorectal Cancer 2001 0.75
57 Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy). Clin Transl Oncol 2006 0.75
58 [Ontogenic study of the structure of the cerebellar structure of Rana ridibunda]. Trab Inst Cajal 1982 0.75
59 Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas: a phase II trial. Am J Clin Oncol 1998 0.75
60 Irinotecan (CPT-11) in metastatic colorectal cancer patients resistant to 5-fluorouracil (5-FU): a phase II study. Methods Find Exp Clin Pharmacol 2003 0.75
61 Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). Ann Oncol 1996 0.75
62 [Electron microscopy of the suprarenal of Didelphys marsupialis. I. Intracytoplasmic microtubular formations in the cortical layer]. Trab Inst Cajal Invest Biol 1971 0.75
63 [Polymyositis as the first symptom of sarcoidosis]. Rev Clin Esp 1981 0.75
64 Light and electron microscopic observations of the oculomotor nucleus in the frog, Rana ridibunda. J Hirnforsch 1983 0.75
65 [Comparative cytoarchitectonia of the thalamus and the preoptic region in several anøuran species (author's transl)]. Trab Inst Cajal 1980 0.75
66 [Adjuvant and palliative treatment of pancreatic cancer]. Gastroenterol Hepatol 1999 0.75
67 Real-world healthcare resource utilization in a European non-small cell lung cancer population: the EPICLIN-Lung study. Curr Med Res Opin 2013 0.75
68 [Relation between chronic alcoholism and arterial pressure]. Med Clin (Barc) 1987 0.75
69 Ultrastructural features of the centralis superior and raphe magnus nuclei in the bat. Folia Morphol (Praha) 1983 0.75
70 The cerebellum of the frog Rana ridibunda. An electron microscopic study. J Hirnforsch 1983 0.75
71 [Pluriglandular autoimmune syndrome. Systematic review]. An Med Interna 2007 0.75
72 Ultrastructural development of raphe nuclei in the bat (Myotis myotis). J Hirnforsch 1983 0.75
73 Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer. Ann Oncol 2004 0.75
74 Oncological translational research in the Spanish national health system: the INTRO study. Clin Transl Oncol 2013 0.75